Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
✍ Scribed by Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M. Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R. Cacciola; Cristina Santoro; Nicola Vianelli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Emma Cacciola; Francesco Rodeghiero; Enrico M. Pogliani; Guido Finazzi; Luigi Gugliotta; Giuseppe Leone; Tiziano Barbui; for the GIMEMA Chronic Myeloproliferative Neoplasms Working Party
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 122 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We read with interest the special article byShneider et al. 1 , which was published in November 2006, but related to a conference held in March 2006. As regards hepatitis B, Shneider et al. state: "Unfortunately at present there are inadequate numbers of patients with sufficiently long follow-up to